Drugs / Bay 50-4798
last change Mar 2005 re-read 3 minutes ago

Bay 50-4798

Developed for
HIV infectious disease
Investigated by
Bayer

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00059462 Dec 2002 → Mar 2005 HIV infectious disease Bayer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bay 50-4798 “HAART and Bay 50-4798” NCT00059462 ↗
Route Subcutaneous “Subcutaneous Bay 50-4798 Administration” NCT00059462 ↗